|
|||||||||||||||||
Perspectives
Martin I. Meltzer, David T. Dennis, and Kathleen A. Orloski
Centers for Disease Control and Prevention, Atlanta, Georgia, USA
![]() |
| Back to article Figure 1: Decision tree to model the cost effectiveness of vaccinating a person against Lyme disease. |
![]() |
| Back to article Figure 2: Average cost effectiveness of vaccinating a person against Lyme disease with changes in the cost of vaccination, probabilities of identifying and treating early Lyme disease, and probabilities of contracting Lyme disease. A negative value indicates that vaccinating a person will result in a net cost to society, while a positive value indicates a net savings to society. The results shown are the means from Monte Carlo simulations (see Table 1 and text for further details). Vaccine assumed 85% effective (Table 1). |
Home | Top of Page | Current Issue | Expedited | Upcoming Issue | Past Issue | EID Search | Contact Us CDC Home | Search | Health Topics A-Z This page last reviewed July 1, 1999 Emerging Infectious Diseases Journal |